North Shore University Hospital

Long Island Jewish Medical Center Appoints Dr. Michael Gitman Executive Director

Retrieved on: 
Monday, November 15, 2021
Nursing, Education, Health, Hospitals, Surgery, Continuing, University, Magnet, Society, Medical Center, Feinstein Institute for Medical Research, American Society of Nephrology, Associate, Centers for Medicare & Medicaid Services, Medicare, MD, Education, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, CEO, Esther Gitman, COVID-19, Mount Sinai Medical Center, Instagram, Multimedia, Transplant, Twitter, North Shore University Hospital, Hospital, Columbia University, LinkedIn, Long Island Jewish Medical Center, Center, Nursing, Physician, Internal medicine, Patient, Medical research, LIJ, American College, Medicine

Northwell Health today announced the appointment of Michael Gitman, MD , to lead Long Island Jewish (LIJ) Medical Center as its executive director.

Key Points: 
  • Northwell Health today announced the appointment of Michael Gitman, MD , to lead Long Island Jewish (LIJ) Medical Center as its executive director.
  • Dr. Gitman has served as medical director at North Shore University Hospital (NSUH) in Manhasset since 2014 and succeeds Michael Goldberg, who departs Northwell to pursue other opportunities outside of the health system.
  • Michael Gitman has a rich family legacy of service to the region and to Long Island Jewish Medical Center in particular, said Michael Dowling , president and CEO at Northwell Health.
  • Dr. Gitman completed his residency and chief residency in internal medicine, as well as a nephrology fellowship at Mount Sinai Medical Center.

Entenmann family names South Shore University Hospital campus with largest gift in the hospital’s history

Retrieved on: 
Tuesday, November 2, 2021
Other Retail, Other Health, Health, Philanthropy, General Health, Food, Beverage, Other Philanthropy, Retail, Hospitals, Foundation, Fitness & Nutrition, Teaching hospital, Paola Lattus, LinkedIn, Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Twitter, History, Family, Patient, Impossible, Medicine, NP, Feinstein Institute for Medical Research, Instagram, Northwell Health, CEO, RN, Multimedia, Medical research, Â, Woman, Health, Nursing, Huntington Hospital, North Shore University Hospital, Entenmann's, Physician, Healthcare, Pharmaceutical industry

South Shore University Hospital (SSUH), Northwell Healths Suffolk County tertiary hospital, received the largest gift in its history from the Entenmann family to support the hospitals ongoing $500 million transformation.

Key Points: 
  • South Shore University Hospital (SSUH), Northwell Healths Suffolk County tertiary hospital, received the largest gift in its history from the Entenmann family to support the hospitals ongoing $500 million transformation.
  • The campus will be named the Entenmann Family Campus at South Shore University Hospital in recognition of the generosity of the family behind the iconic baked goods company.
  • View the full release here: https://www.businesswire.com/news/home/20211102005884/en/
    Entenmann family members and Northwell Health executives celebrate the familys gift to South Shore University Hospital, the largest in the hospitals history.
  • Video: Hear from the Entenmann family and Northwell Health leaders about the familys transformational gift to South Shore University Hospital.

Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health Limited

Retrieved on: 
Friday, October 22, 2021
Linda, Medicine, Technology, Annual report, Association, Montefiore Medical Center, Association of American Physicians and Surgeons, The Company, Physician, Patient, Private Securities Litigation Reform Act, NASDAQ, HX, Radiation, North Shore University Hospital, Terminology, U.S. Securities and Exchange Commission, SEC, Risk, University of Medical Sciences, Company, Albert Einstein College of Medicine, Mount Sinai Hospital, COVID-19, Securities Exchange Act of 1934, Sun, Medical device

BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company.

Key Points: 
  • BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company.
  • Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited.
  • Dr. Liu received his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China.
  • Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc., ("Xiaobai Maimai" or the "Company"), is currently engaged in two lines of business, i.e.

ChemoCentryx Appoints Rita I. Jain, M.D. as Executive Vice President, Chief Medical Officer

Retrieved on: 
Monday, October 11, 2021
Nephrology, Oklahoma Office of the Chief Medical Examiner, State university system, Pain, Inflammation, Pharmacovigilance, Fellow, Degenerative disease, Therapy, Internal medicine, Hidradenitis suppurativa, Biology, Adult, Abbott Laboratories, ANCA, Metabolism, SAN, Health, Director, Drug development, GLOBE, Laboratory, The Stony Brook School, Cancer, North Shore University Hospital, AbbVie, Divisional Railway Hospital, Golden Rock, University, Assistant, Staten Island University Hospital, Senior, University of Texas Southwestern Medical Center, Akebia, New York University Grossman School of Medicine, Leadership, Pharmacia, Arthritis, Science, Patient, University School, Nasdaq, G.D. Searle, LLC, Management, Pharmaceutical industry

SAN CARLOS, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the appointment of Rita I. Jain, M.D., as Executive Vice President, Chief Medical Officer. In this role, she will oversee development activities including clinical development, development operations, regulatory affairs, and drug safety and pharmacovigilance. Dr. Jain will continue to serve on the ChemoCentryx board of directors (where she has served since March of 2019) as an executive employee director. Dr. Jain, a board-certified rheumatologist, brings more than 20 years of drug development experience leading multiple global programs across early and late stages of development.

Key Points: 
  • SAN CARLOS, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the appointment of Rita I. Jain, M.D., as Executive Vice President, Chief Medical Officer.
  • Dr. Jain will continue to serve on the ChemoCentryx board of directors (where she has served since March of 2019) as an executive employee director.
  • "Today we bolster our strength as an organization - and across a range of extremely important therapeutic areas - by bringing Rita Jain to the ChemoCentryx leadership team, said Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx.
  • Additionally, ChemoCentryx has early-stage drug candidates that target chemoattractant receptors in other inflammatory and autoimmune diseases and in cancer.

Northwell Gives COVID-19 Booster Vaccine to Nurse Sandra Lindsay, Staff

Retrieved on: 
Wednesday, October 6, 2021
FDA, Other Health, Pharmaceutical, Practice Management, Managed Care, General Health, Infectious Diseases, Hospitals, Clinical Trials, Science, Biotechnology, Nursing, Health, Research, Medical Supplies, Lenox Hill Hospital, Northwell Health, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Compliance, LIJ, DNP, Instagram, Courage, COVID-19, White House, Immunity, Medical research, Multimedia, Physician, Cohen, LinkedIn, Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Nursing, Twitter, Feinstein Institute for Medical Research, Medicine, Teaching hospital, Disease, North Shore University Hospital, Risk, Science, Pfizer, Pediatrics, NP, Emergency medicine, Finger, Vaccination, RN, Pharmaceutical industry, Vaccine

View the full release here: https://www.businesswire.com/news/home/20211006005964/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211006005964/en/
    Ms. Lindsay enthusiastically held high three fingers moments after Michelle Chester, DNP, director of Northwell Health Employee Health Services, administered the booster shot in front of reporters.
  • On Wednesday, Ms. Lindsay was back in front of cameras, one of five frontline health care workers who publicly received their booster shot.
  • And now, after this most difficult year, we are delighted to be able to offer our team members a booster shot of the Pfizer vaccine.
  • For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook , Twitter , Instagram and LinkedIn .

North Shore University Hospital Unveils $325M Surgical Pavilion

Retrieved on: 
Thursday, May 20, 2021
General Health, Surgery, Other Health, Hospitals, Health, Northwell Health, Hospitals, Town of North Hempstead, New York, North Shore University Hospital, Michael Dowling, North Shore, Health care

b'After more than a decade of planning and 13 months into the construction of the $325 million Petrocelli Advanced Surgical Pavilion, North Shore University Hospital (NSUH) today held a steel beam topping off ceremony to signal Northwell Health\xe2\x80\x99s ongoing commitment to delivering quality, state-of-the-art care to the region.\nThis press release features multimedia.

Key Points: 
  • b'After more than a decade of planning and 13 months into the construction of the $325 million Petrocelli Advanced Surgical Pavilion, North Shore University Hospital (NSUH) today held a steel beam topping off ceremony to signal Northwell Health\xe2\x80\x99s ongoing commitment to delivering quality, state-of-the-art care to the region.\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210520006033/en/\nFrom left: North Shore University Hospital Executive Director Jon Sendach, with donors Jill and Michael Lamoretti, Northwell Health President and CEO Michael Dowling and donors Michael and Melissa Weinbaum.
  • \xe2\x80\x9cThis impressive facility is the realization of a lot of planning and work that goes back more than a decade.
  • It will serve to magnify all of the great things already happening at North Shore University Hospital.\xe2\x80\x9d\nThe pavilion will feature 18 operating rooms, including three hybrid operating suites with advanced imaging, 44 intensive care unit beds, a lobby at the Sandra Atlas Bass Heart Hospital and two levels of parking under the building.

Feinstein Institutes Clinical Research to Study Experimental Stroke Drug

Retrieved on: 
Tuesday, May 11, 2021
Health, Science, Research, Clinical trials, Cardiology, Feinstein Institute for Medical Research, Manhasset, New York, North Shore University Hospital, National Institutes of Health, Stroke, Medical research, Hospitals, Health care, Health

View the full release here: https://www.businesswire.com/news/home/20210511005781/en/\nRichard Temes, MD, Northwell Health\xe2\x80\x99s director, Center for Neurocritical Care (Credit: The Feinstein Institutes for Medical Research)\nThe study, entitled \xe2\x80\x9cRecombinant Factor Vlla (rFVlla) for Acute Hemorrhagic Stroke Administered at Earliest Time,\xe2\x80\x9d also referred to as the FASTEST trial, is funded by the National Institutes of Health (NIH).

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210511005781/en/\nRichard Temes, MD, Northwell Health\xe2\x80\x99s director, Center for Neurocritical Care (Credit: The Feinstein Institutes for Medical Research)\nThe study, entitled \xe2\x80\x9cRecombinant Factor Vlla (rFVlla) for Acute Hemorrhagic Stroke Administered at Earliest Time,\xe2\x80\x9d also referred to as the FASTEST trial, is funded by the National Institutes of Health (NIH).
  • The research will be conducted at North Shore University Hospital (NSUH), a comprehensive stroke center.
  • The study medicine will be given within two hours of stroke onset.
  • Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.

Northwell Health Outlines Safety, Financial Steps Taken During COVID-19 Crisis

Retrieved on: 
Wednesday, December 2, 2020
Mental health, Nursing, Infectious diseases, Human resources, Hospitals, Professional services, Practice Management, Managed care, General Health, Health, Northwell Health, Town of North Hempstead, New York, Feinstein Institute for Medical Research, Michael Dowling, Hospitals, Health care, North Shore University Hospital

View the full release here: https://www.businesswire.com/news/home/20201202005960/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201202005960/en/
    Michael Dowling, president and CEO of Northwell Health poses with some of Northwells frontline heroes.
  • (Credit: Northwell Health)
    From equipment to staffing and testing, as the crisis ramped up, Northwell Health looked to address urgent needs.
  • The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State.
  • Our 74,000 employees 18,500 nurses and 4,500 employed doctors, including members of Northwell Health Physician Partners are working to change health care for the better.

Northwell Health partners with TeleTracking to bring real-time bed visibility to New York health system

Retrieved on: 
Thursday, November 12, 2020
Northwell Health, Town of North Hempstead, New York, Trauma center, Hospitals, Nassau County, New York, New York Institute of Technology, Long Island, North Shore University Hospital

Northwell Health was squarely in the epicenter of the COVID-19 crisis that unfolded across greater New York City this past spring.

Key Points: 
  • Northwell Health was squarely in the epicenter of the COVID-19 crisis that unfolded across greater New York City this past spring.
  • The extension of this agreement will allow Northwell Health to now see all available beds across the system.
  • The comprehensive, enterprise view of bed capacity across all 19 Northwell Health sites will allow the system to meet their community responsibilities and fulfill their mission.
  • Northwell Health is New York States largest health care provider and private employer, with 23 hospitals and nearly 800 outpatient facilities.

Health Catalyst and Northwell Health Partner to Transform Patient Care with Cloud-Based Data and Analytics Enterprise Solution

Retrieved on: 
Wednesday, August 12, 2020
Northwell Health, New York state), Healthcare in New York, Town of North Hempstead, New York, Long Island, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Feinstein Institute for Medical Research, Hofstra University, North Shore University Hospital, Plainview Hospital

The solutions will be used across the Northwell Health enterprise, which includesthe Feinstein Institute and Donald and Barbara Zucker School of Medicine at Hofstra.

Key Points: 
  • The solutions will be used across the Northwell Health enterprise, which includesthe Feinstein Institute and Donald and Barbara Zucker School of Medicine at Hofstra.
  • Northwell Health is New York State's largest health care provider and private employer, with 23 hospitals, nearly 800 outpatient facilities and more than 18,500 affiliated physicians.
  • "We are honored to have the opportunity to join Northwell Health on its mission-driven journey to transform healthcare," saidDan Burton, CEO of Health Catalyst.
  • Northwell Health is New York State's largest health care provider and private employer, with 23 hospitals, 665 outpatient facilities and more than 18,500 affiliated physicians.